ArticleMolecular cancer therapeutics2026

A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells.

Laura G Volta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.